HEXO Stock: Is the Cannabis Giant a Buy Right Now?

Down 95% from all-time highs, HEXO stock continues to remain a high-risk bet for growth investors.

| More on:

Shares of Canadian cannabis giant HEXO (TSX:HEXO)(NASDAQ:HEXO) rose by over 10% in the first half of 2021. However, since then, the stock has wiped off these gains and is now down over 50% year to date. The cannabis stock is now down 95% from record highs, burning significant investor wealth in the process.

Generally, you look at a company’s revenue and earnings growth to make an investment decision. But it’s difficult for cannabis companies to keep delivering top-line growth and earnings improvement, as the industry is grappling with a wide array of structural issues. Further, the cannabis industry is at a nascent stage, which has attracted several players, thereby increasing competition resulting in a price war to capture market share.

So, marijuana producers, including HEXO, have been hit by widening losses, which have led to multiple equity capital raises in the past, resulting in an accelerated dilution of shareholder wealth in recent years.

Investors also need to consider a company’s cash flow from operations to see if the entity is burning through cash with respect to day-to-day activities, which will then result in further shareholder dilution and a corresponding decline in stock price. For example, in August 2021, HEXO stock lost over 25% in a single trading session after the company announced its plan to raise over $175 million via an equity offering.

HEXO stock remains vulnerable

In the last 12 months, HEXO has burnt close to $20 million to fund its operational activities. In its fiscal third quarter of 2021 (ended in July), HEXO reported a cash balance of $194 million, which provides the company with enough leeway to improve its cash flows in the future. However, HEXO has been on an acquisition spree this year and disclosed three big-ticket acquisitions in the first five months of 2021. These acquisitions will be funded via a combination of company stock and cash, both of which will weigh on HEXO’s already weak financials.

Investors who are bullish on HEXO stock will argue that the company’s acquisition of Redecan, which is the largest privately held cannabis producer in Canada, will allow the former to gain significant traction in Canada’s recreational marijuana market. But can HEXO afford to keep raising capital and fund its expansion plans?

Similar to other Canadian cannabis producers, HEXO is also eyeing expansion south of the border for when pot is legalized at the federal level. A few months back, HEXO acquired a cannabis facility in Colorado for $6 million. But it will spend around $50 million to upgrade the facility, which is a matter of grave concern.

What’s next for HEXO stock?

HEXO is currently valued at a market cap of $603 million. The company has increased its revenue from just $4.9 million in fiscal 2018 to $80.78 million in fiscal 2020. But its operating losses have also widened from $17.9 million to $163 million in this period. If interest rates rise, it will negatively impact HEXO’s balance sheet, as the company has already paid $11 million in interest and financing expenses in the last 12 months, accounting for almost 10% of total sales in this period.

HEXO might continue to raise debt to fund its acquisition plans, which suggest the marijuana company has to reduce cash burn at a rapid clip to gain investor confidence. Despite the company’s less-than-impressive financials, Bay Street expects HEXO stock to more than double to $5.51 per share in the next 12 months.

Fool contributor Aditya Raghunath has no position in any of the stocks mentioned. The Motley Fool recommends HEXO Corp.

More on Cannabis Stocks

Farmer smiles near cannabis crop
Cannabis Stocks

TFSA Investors: An Undervalued Cannabis Stock You Can Buy for $500 Right Now

Down almost 70% from all-time highs, Curaleaf is a TSX cannabis stock that trades at an attractive valuation in December…

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Can Canopy Growth Stock Finally Recover in 2026, as Donald Trump Might Ease Cannabis Restrictions?

Down over 99% from all-time highs, Canopy Growth stock might recover in 2026 if the Trump administration reclassifies cannabis products.

Read more »

Researcher works in hemp field
Cannabis Stocks

Forget Tilray and Buy This Cannabis Stock if the U.S. Reclassifies Marijuana in 2026

While Tilray stock gained over 40% on Friday, this cannabis company is a better buy if the U.S. reclassifies marijuana…

Read more »

A cannabis plant grows.
Cannabis Stocks

Aurora Cannabis Surged 21% on Possible Cannabis Reclassification in the U.S. Is ACB Stock Finally a Good Buy?

Down almost 99% from all-time highs, Aurora Cannabis is a beaten-down marijuana stock that offers upside potential in December 2025.

Read more »

four people hold happy emoji masks
Dividend Stocks

Wary of Mining Companies? A Lower-Risk Way to Get in on the Gold and Silver Surge

Frenco-Nevada (TSX:FNV) stock might be a wiser way to play the run in gold prices this year.

Read more »

Cannabis smoke
Cannabis Stocks

Have Cannabis Stocks Totally Gone Up in Smoke?

Let's dive into whether Canadian cannabis stocks are still investable, and what investors should make of the recent volatility in…

Read more »

Researcher works in hemp field
Cannabis Stocks

1 Undervalued Cannabis Stock to Buy and Hold Over the Next Decade

Green Thumb is a beaten-down cannabis stock that trades at a compelling valuation in September 2025.

Read more »

Researcher works in hemp field
Cannabis Stocks

Pot Stocks Rallied Hard in August: Is There More to Come?

Tilray Brands (TSX:TLRY) and the broad basket of pot stocks could heat up from here.

Read more »